FACCTs

About FACCTs

FACCTs develops fast and accurate simulation tools for chemical and pharmaceutical R&D, focusing on quantum-chemical methods and user-friendly workflows. As a spin-off of the Max Planck Society, the company centers on the ORCA quantum-chemical software and WEASEL, enabling researchers to apply physics-based models to molecular problems across academia and industry. Their offerings cover computational chemistry software beyond traditional approaches, including structure elucidation, reaction optimization, and scientific consulting services for labs and pharmaceutical companies. FACCTs operates globally with a strong research pedigree and a user base spanning scientists who rely on precise quantum chemical calculations in daily work.